Welcome to Coulter Partners Global (English)

09 April 2024

Top hires for VC & PE portfolio companies Q1-2024

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Therapeutic devices Austria
Chief Business Officer Precision biologics US
Chief Financial Officer Remote monitoring France
Chief Strategy Officer Medical devices Israel
Chief Medical Officer Radiopharmaceuticals US
Chief of Staff Vaccines Denmark
VP Global Program Leader, Respiratory Multi-modality biotech UK
VP Technology & Product Development DNA technology UK
Controller Contract manufacturing US
Senior Director Pharmaceutical Development Drug delivery Ireland
Director Market Access & Pricing Global Ophthalmology Italy
Investment Manager Digital Health Life sciences investor Netherlands
General Manager Infectious Diseases Biocluster France
Board Director Personalized digital health Switzerland
Board Director Electronic medical instrumentation US
Board Director Immunotherapies Sweden

Newly opened projects include:

Function Focus area Location
CEO Medical devices Belgium
CEO Precision medicines US
Chief Commercial Officer Contract research organization (CRO) UK
Chief Development Officer Protein degradation DACH
Chief Scientific Officer Small molecules Spain
Chief Financial Officer Gene therapy US
Chief Operating Officer Incubator/ tech transfer UK
Head of Strategy & Commercial Excellence Drug delivery systems Germany
SVP, Head of Business Development Drug discovery services Germany
VP of Science Precision nutrition UK
VP, Head of Translational Development Gene editing Spain
VP Research & Preclinical Synthetic biology UK
VP Business Development tRNA technologies US
Life Sciences Partner Life sciences investor Italy
Board Director T-cell therapies US/ Europe


A new version of Coulter Partners is available.